Nurse Practitioner in Fort Wainwright, AK Accepting Medicare

8 Nurse Practitioner nurses found. Showing 1 - 8

Mrs. Audry Marie Torres, FAMILY NURSE PRACTIT Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1060 Gaffney Rd, Fort Wainwright, AK 99703 Phone: 907-361-5326

Monica Wyatt, RN Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 1060 Gaffney Rd, Fort Wainwright, AK 99703 Phone: 907-361-5930

Chad Brian Gooderham, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1060 Gaffney Rd, Fort Wainwright, AK 99703 Phone: 907-353-5286

Christina C Hudson, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1060 Gaffney Rd, Fort Wainwright, AK 99703 Phone: 907-361-0229

Ms. Mary M. Nevin, ANP Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1060 Gaffney Rd, Fort Wainwright, AK 99703 Phone: 907-353-4126

Emily Jean Lugdon, FNP-C APRN Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1060 Gaffney Rd, Fort Wainwright, AK 99703 Phone: 907-361-5172

Lorna D Newman-hill, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 4076 Neely Rd, Fort Wainwright, AK 99703 Phone: 907-361-5611

Heather Guess, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1060 Gaffney Rd, Bassett Army Community Hospital, Fort Wainwright, AK 99703 Phone: 907-353-5418    Fax: 907-353-4845

News Archive

UC-CCHMC partnership receives $3.75M NIAMS grant for musculoskeletal soft tissue repair research

An award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will aid a partnership between the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center (CCHMC) in finding new ways to use adult stem cells to speed repair of musculoskeletal soft tissue injuries.

FDA Drugs Advisory Committee recommends approval for Gilead Sciences' aztreonam for inhalation solution

Gilead Sciences, Inc. today announced that the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has recommended that aztreonam for inhalation solution be approved for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF).

Medical error is the fifth-leading cause of death in the U.S.

Millennium Research Group (MRG) has conducted a detailed and thorough analysis of the acute care clinical information systems (CIS) market and finds that a major driver in the US is the demand for improvement in patient safety.

BRAVADA expands Women's Athletica stores

BRAVADA International announced today expansion plans of its BRAVADA Women's Athletica stores through high traffic commercial shopping malls across North America.

PPMD, Santhera Pharmaceuticals collaborate to study Duchenne muscular dystrophy

Parent Project Muscular Dystrophy, the leading advocacy organization working to end Duchenne muscular dystrophy (Duchenne) and Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases, will collaborate on a benefit/risk study in Duchenne.

Read more Medical News

› Verified 9 days ago